Shamburg News · 8-K filed Nov 13, 2026, 4:15 PM EST

DataMEDS AI Reports Q3 2026 Net Profit of $2.72 Per Diluted Share on 50% Sequential Revenue Growth

MEDS · DataMeds AI, Inc.

  • Earnings
  • Acquisition
  • Material agreement
  • Other event
  • Materiality: high

DataMEDS AI, Inc. reported net revenues of $2,668,980 for the third quarter ended September 30, 2026, compared with $3,012,904 in the prior-year quarter, and a Q3 2026 net income of $10,535,560 driven largely by a $19,064,881 gain on extinguishment of debt. Diluted net profit per share was $2.72 on 3,961,210 weighted average shares, compared with a loss of $23.07 per share in the third quarter of 2025. The press release also described a business update, including the Health Lives Here app launch, an exclusive REBOOT GLP-1 license, compounded peptides, a non-binding HMO memorandum of understanding, the Helomics acquisition, and regained Nasdaq compliance.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001493152-26-051734.

Written from the filing by Shamburg Markets. Figures are as reported by the company.